SALL4
Basic information
Region (hg38): 20:51782331-51802521
Links
Phenotypes
GenCC
Source:
- Duane-radial ray syndrome (Strong), mode of inheritance: AD
- Duane-radial ray syndrome (Definitive), mode of inheritance: AD
- Duane retraction syndrome (Supportive), mode of inheritance: AD
- IVIC syndrome (Supportive), mode of inheritance: AD
- Duane-radial ray syndrome (Definitive), mode of inheritance: AD
- Duane-radial ray syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Duane-radial ray/Okohiro syndrome; IVIC syndrome | AD | Audiologic/Otolaryngologic; Cardiovascular; Renal | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Individuals have been described with vesicoureteral reflux, and surveillance and management may be helpful to preserve renal function; The conditions can involve congenital cardiac anomalies, and awareness may allow early management | Audiologic/Otolaryngologic; Cardiovascular; Craniofacial; Endocrine; Gastrointestinal; Hematologic; Musculoskeletal; Ophthalmologic; Renal | 843249; 7395922; 12395297; 11826030; 12393809; 12789647; 12843316; 12868480; 15342710; 16086360; 16402211; 16411190; 17256792; 20301547 |
ClinVar
This is a list of variants' phenotypes submitted to
- Duane-radial ray syndrome (20 variants)
- not provided (4 variants)
- SALL4-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SALL4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 85 | 101 | ||||
missense | 133 | 10 | 149 | |||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 17 | 25 | ||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 4 | 4 | ||||
non coding | 11 | 19 | ||||
Total | 24 | 8 | 148 | 103 | 25 |
Variants in SALL4
This is a list of pathogenic ClinVar variants found in the SALL4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-51784019-CA-C | Likely benign (Aug 25, 2018) | |||
20-51784019-C-CAA | Benign (Jan 12, 2020) | |||
20-51784053-A-AT | Benign (Sep 09, 2019) | |||
20-51784140-A-T | Benign (Mar 03, 2015) | |||
20-51784266-T-C | Uncertain significance (Nov 11, 2016) | |||
20-51784274-C-T | Duane-radial ray syndrome | Conflicting classifications of pathogenicity (Dec 31, 2019) | ||
20-51784275-G-A | Duane-radial ray syndrome | Uncertain significance (Feb 01, 2024) | ||
20-51784299-T-G | Inborn genetic diseases | Uncertain significance (Sep 14, 2022) | ||
20-51784322-G-A | Duane-radial ray syndrome | Benign/Likely benign (Apr 01, 2024) | ||
20-51784324-C-T | Duane-radial ray syndrome • Inborn genetic diseases • SALL4-related disorder | Conflicting classifications of pathogenicity (Jan 29, 2024) | ||
20-51784329-G-A | Inborn genetic diseases • SALL4-related disorder | Uncertain significance (Jan 26, 2022) | ||
20-51784330-T-C | Duane-radial ray syndrome | Uncertain significance (Nov 19, 2019) | ||
20-51784331-A-G | Duane-radial ray syndrome | Likely benign (May 16, 2021) | ||
20-51784347-A-C | Duane-radial ray syndrome • Oculootoradial syndrome;Duane-radial ray syndrome | Uncertain significance (Mar 02, 2022) | ||
20-51784351-C-A | Inborn genetic diseases | Uncertain significance (Mar 19, 2024) | ||
20-51784365-G-A | Inborn genetic diseases • Duane-radial ray syndrome | Conflicting classifications of pathogenicity (Sep 24, 2023) | ||
20-51784368-TG-T | Duane-radial ray syndrome | Likely pathogenic (-) | ||
20-51784396-C-T | Duane-radial ray syndrome | Uncertain significance (Aug 24, 2023) | ||
20-51784397-G-A | Duane-radial ray syndrome | Likely benign (Dec 13, 2021) | ||
20-51784416-GC-G | Uncertain significance (Apr 13, 2021) | |||
20-51784425-G-A | Duane-radial ray syndrome | Uncertain significance (Nov 10, 2022) | ||
20-51784436-G-A | Likely benign (Apr 09, 2018) | |||
20-51784443-A-C | Duane-radial ray syndrome | Uncertain significance (Feb 25, 2021) | ||
20-51784443-AC-A | Uncertain significance (Mar 22, 2023) | |||
20-51784445-C-A | Duane-radial ray syndrome | Likely benign (May 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SALL4 | protein_coding | protein_coding | ENST00000217086 | 4 | 18479 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000285 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.07 | 539 | 614 | 0.878 | 0.0000400 | 6896 |
Missense in Polyphen | 151 | 219.69 | 0.68733 | 2561 | ||
Synonymous | -2.39 | 320 | 270 | 1.18 | 0.0000205 | 2202 |
Loss of Function | 5.04 | 0 | 29.5 | 0.00 | 0.00000195 | 340 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000145 | 0.000145 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.000141 | 0.000114 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells. {ECO:0000269|PubMed:23012367}.;
- Disease
- DISEASE: Duane-radial ray syndrome (DRRS) [MIM:607323]: Disorder characterized by the association of forearm malformations with Duane retraction syndrome. {ECO:0000269|PubMed:12393809, ECO:0000269|PubMed:12395297, ECO:0000269|PubMed:16402211}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Oculootoradial syndrome (OORS) [MIM:147750]: Autosomal dominant condition characterized by upper limbs anomalies (radial ray defects, carpal bones fusion), extraocular motor disturbances, congenital bilateral non-progressive mixed hearing loss. Other less consistent malformations include heart involvement, mild thrombocytopenia and leukocytosis (before age 50), shoulder girdle hypoplasia, imperforate anus, kidney malrotation or rectovaginal fistula. The IVIC syndrome is an allelic disorder of Duane-radial ray syndrome (DRRS) with a similar phenotype. {ECO:0000269|PubMed:17256792}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Transcriptional regulation of pluripotent stem cells;Vitamin D Receptor Pathway;Wnt-beta-catenin Signaling Pathway in Leukemia;Developmental Biology;Signal Transduction;Regulation of PTEN gene transcription;PTEN Regulation;PIP3 activates AKT signaling;Transcriptional regulation of pluripotent stem cells;Intracellular signaling by second messengers;Regulation of nuclear beta catenin signaling and target gene transcription
(Consensus)
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- loftool
- 0.0991
- rvis_EVS
- -1.47
- rvis_percentile_EVS
- 3.73
Haploinsufficiency Scores
- pHI
- 0.622
- hipred
- Y
- hipred_score
- 0.741
- ghis
- 0.514
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.811
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sall4
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;inner cell mass cell proliferation;neural tube closure;ventricular septum development;regulation of transcription, DNA-templated;embryonic limb morphogenesis;somatic stem cell population maintenance;positive regulation of transcription by RNA polymerase II
- Cellular component
- heterochromatin;nucleus;nucleoplasm;cytoplasm;protein-containing complex;intracellular membrane-bounded organelle
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;transcription factor binding;metal ion binding